Artificial intelligence-assisted hemodialysis patients outcomes prediction and therapy: a multicenter randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052662

Enrollment

Unknown

Registered

2021-11-03

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Experimental group:AI-enabled High risk patients Screening Tool

Control group:routine practice

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Clinicians who are part of a participating care team that care for hemodialysis patients and have the right to prescribe.

Exclusion criteria

Exclusion criteria: The number of long-term maintenance hemodialysis patients in the dialysis center was less than 50.

Design outcomes

Primary

Measure	Time frame
Average monthly mortality rate of patients in dialysis centers;	—

Secondary

Measure	Time frame
Average monthly readmission rate of patients in dialysis centers;	—

Countries

China

Contacts

Public ContactChen Jianghua

The First Affiliated Hospital, Zhejiang University School of Medicine

zjukidney@zju.edu.cn+86 13905824085

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026